7 completed. 3 Phase 3, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Not applicable | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Paget's Disease of Bone: new trials by email Literature Review of Paget's Disease of Bone trials Research Report on Paget's Disease of Bone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pathophysiology of Paget's Disease of Bone Paget's Disease of Bone | Completed | Johns Hopkins University | 11 | 2016-04-01 | 2024-11-20 | |
| Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB) Zoledronic acid - Paget's Disease of Bone | Phase 4 | Completed | Novartis Pharmaceuticals | 9 | 2008-10-30 | 2017-02-23 |
| Genetic Study of Families Affected by Paget's Disease of Bone Paget's Disease of Bone | Completed | Assistance Publique - Hôpitaux de Paris | 83 | 2007-09-01 | 2010-07-13 | |
| Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period zoledronic acid, placebo to zoledronic acid, Risedronate - Paget's Disease of Bone | Phase 3 | Completed | Novartis Pharmaceuticals | 185 | 2002-04-01 | 2012-06-04 |
| 18F-Fluoride Positron Emission Tomography (PET) in Paget's Disease of Bone Bisphosphonate treatment - Paget's Disease of Bone | Not applicable | Completed | Université Catholique de Louvain | 20 | 2002-02-01 | 2006-03-22 |
| A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED) alendronate - Paget's Disease of Bone | Phase 3 | Completed | Organon and Co | 60 | 2001-10-01 | 2024-08-14 |
| Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period Zoledronic Acid, Risedronate, Placebo to Risedronate - Paget's Disease of Bone | Phase 3 | Completed | Novartis Pharmaceuticals | 172 | 2001-01-01 | 2012-05-15 |
Bone Diseases (7) · Musculoskeletal Diseases (7)
Zoledronic Acid (3) · Calcium (2) · Risedronic Acid (2) · Alendronate (1) · Vitamin D (1)
Novartis Pharmaceuticals (3) · Assistance Publique - Hôpitaux de Paris (1) · Johns Hopkins University (1) · Organon and Co (1) · Université Catholique de Louvain (1)
United States (3) · Australia (2) · Belgium (2) · Canada (2) · France (2) · New Zealand (2) · Spain (2) · United Kingdom (2) · China (1) · Germany (1) · South Africa (1)
Janet L Crane, M.D. (1) · Laetitia Michou, MD PhD (1)